Trial Profile
A phase I pilot study of Triapine [OCX 0191] and cytarabine in patients with hematologic malignancies
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs OCX 191 (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Chronic myeloid leukaemia; Chronic myelomonocytic leukaemia; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 22 Sep 2005 New trial record.